Social Media Content Creators Driving Parallel Trade for Unlicensed Weight-Loss Drug

A shadow market for unapproved slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a robust trade exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and claims of next-day British shipping. Sellers promote the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, doctors and chemists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Material Removal

According to the social media company, the service has taken down problematic content and prohibited related keywords and search suggestions. The company said it was dedicated to keeping the service secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.

After minutes of entering one community, a seller shared contact information, where most transactions take place. The vendor provided an guidebook and promised delivery within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, health issues or previous experience.

Product Information and Pricing

Within these communities, messages show dark colored parcels with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram said it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has already encountered patients harmed by self-injection from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet approved … may subject patients to possibly serious health risks”.

Dylan Carter
Dylan Carter

A lighting technology expert with over a decade of experience in smart home automation and sustainable energy solutions.